基于网络药理学和实验验证探讨涤痰汤治疗阿尔茨海默病作用机制OA
Study on the Mechanism of Ditan Decoction in Treating Alzheimer Disease Based on Network Pharmacology and Experimental Verification
目的 基于网络药理学及动物实验探讨涤痰汤治疗阿尔茨海默病(AD)的作用机制.方法 通过TCMSP数据库检索涤痰汤活性成分及相关靶点,OMIM、GeneCards数据库搜集AD靶点,利用STRING数据库构建靶蛋白相互作用网络,用R语言对关键靶点进行GO和KEGG富集分析.大鼠双侧海马注射β-淀粉样蛋白25-35制备AD模型,将大鼠分为假手术组、模型组、多奈哌齐组、涤痰汤低剂量组、涤痰汤高剂量组、涤痰汤高剂量+AMPK抑制剂组,并予相应干预,HE染色观察海马组织形态,透射电镜观察海马区神经元和突触超微结构,ELISA检测海马组织炎症因子含量,Western blot检测海马组织腺苷酸活化蛋白激酶(AMPK)、磷酸化AMPK(p-AMPK)、NOD样受体蛋白3(NLRP3)、含CARD结构域的凋亡相关斑点样蛋白(ASC)、胱天蛋白酶-1(Caspase-1)、N端-消皮素D(GSDMD-N)、生长相关蛋白43(GAP43)、突触素(SYN)、突触后致密蛋白95(PSD95)、脑源性神经营养因子(BDNF)蛋白表达,实时荧光定量PCR检测海马组织AMPK、NLRP3、ASC、Caspase-1、GSDMD-N、GAP43、SYN、PSD95、BDNF mRNA表达.结果 筛选出涤痰汤活性成分129个及其治疗AD靶点102个,核心靶点为NLRP3、CASP1、GAP43、SYN1、GSDMD、IL1B、BDNF、TNF、CREB1、APP,KEGG通路富集分析提示,AMPK信号通路、NOD样受体信号通路、胆碱能突触、阿尔茨海默病及谷氨酸能突触可能起核心调控作用.动物实验显示,涤痰汤能提高模型大鼠学习记忆能力(P<0.05,P<0.01),减轻海马组织病理损伤,改善海马区神经元和突触超微结构;降低海马组织IL-1β、IL-18、TNF-α含量(P<0.05,P<0.01),下调ASC、Caspase-1、GSDMD-N蛋白及mRNA表达(P<0.05,P<0.01),上调GAP43、SYN、PSD95、BDNF蛋白及mRNA表达(P<0.05,P<0.01),提升AMPK磷酸化水平以下调NLRP3蛋白及mRNA表达(P<0.05,P<0.01),AMPK抑制剂可部分逆转涤痰汤对细胞焦亡和突触可塑性的影响.结论 涤痰汤可通过抑制AMPK/NLRP3介导的细胞焦亡,改善AD的突触可塑性.
Objective To explore the mechanism of Ditan Decoction in the treatment of Alzheimer disease(AD)based on network pharmacology and animal experiments.Methods Active components and corresponding targets of Ditan Decoction were retrieved through the TCMSP databases;the targets of AD were searched through the OMIM and GeneCards databases,and protein-protein interaction network map was constructed through STRING online database.GO and KEGG enrichment analysis of key targets were carried out by using R language.AD model was established by injecting β-amyloid25-35 into bilateral hippocampus of rats.The rats were divided into sham-operation group,model group,donepezil group,Ditan Decoction low-and high-dosage groups,Ditan Decoction high-dosage+AMPK inhibitor group,and were intervened accordingly.The pathomorphological changes in the hippocampus were observed by HE staining.Transmission electron microscope was used to detect the ultrastructural observation of neurons and synapses in rat hippocampus.The content of inflammatory factors in hippocampus was detected by ELISA.The expressions of AMPK,p-AMPK,NLRP3,ASC,Caspase-1,GSDMD-N,GAP43,SYN,PSD95,BDNF proteins in the hippocampus were detected by Western blot.The mRNA expression of AMPK,NLRP3,ASC,Caspase-1,GSDMD-N,GAP43,SYN,PSD95 and BDNF were detected by RT-qPCR.Results A total of 129 active components of Ditan Decoction and 102 main targets for treating AD were screened,with the core targets including NLRP3,CASP1,GAP43,SYN1,GSDMD,IL1B,BDNF,TNF,CREB1 and APP.KEGG pathway enrichment analysis suggested that AMPK signaling pathway,NOD like receptor signaling pathway,cholinerqic synapse,AD and gluta-matergic synapse may play a core regulatory role.Animal experiments showed that Ditan Decoction could improve the learning and spatial memory abilities of model rats significantly(P<0.05,P<0.01),alleviate pathological morphology damage in hippocampal tissue,and improve the ultrastructure of neurons and synapses in hippocampus;decrease the contents of IL-1β,IL-18 and TNF-α in hippocampus(P<0.05,P<0.01),down-regulate the expressions of ASC,Caspase-1,GSDMD-N proteins and mRNA(P<0.05,P<0.01),and up-regulate the expressions of GAP43,SYN,PSD95,BDNF proteins and mRNA(P<0.05,P<0.01).Ditan Decoction could increase the phosphorylated level of AMPK,thus down-regulate the expression of NLRP3 protein and mRNA(P<0.05,P<0.01).However,the co-treatment of AMPK inhibitor partially reversed the effects of Ditan Decoction on pyroptosis and synaptic plasticity.Conclusion Ditan Decoction can improve synaptic plasticity in AD via inhibiting AMPK/NLRP3-mediated pyroptosis.
张运辉;杨昆;杨梦琳;李勇华;伍大华;刘霞;程妍
重庆三峡医药高等专科学校,重庆 404120重庆三峡医药高等专科学校,重庆 404120重庆三峡医药高等专科学校,重庆 404120重庆三峡医药高等专科学校,重庆 404120湖南中医药大学,湖南 长沙 410208||湖南省中医药研究院附属医院,湖南 长沙 410006重庆三峡医药高等专科学校,重庆 404120重庆三峡医药高等专科学校,重庆 404120
医药卫生
涤痰汤网络药理学阿尔茨海默病细胞焦亡AMPK/NLRP3信号通路
Ditan Decoctionnetwork pharmacologyAlzheimer diseasepyroptosisAMPK/NLRP3 signaling pathway
《中国中医药信息杂志》 2026 (4)
24-32,9
国家自然科学基金(82374441)重庆三峡医药高等专科学校-校级重点项目(XJ2022000505)重庆市中医药传承创新团队-三峡库区道地药材保护与利用多学科交叉创新团队(CXTD202303)重庆市中医药管理局针灸推拿智能装备重点实验室(2024年)重庆市中医药重点学科(中医基础理论)建设项目(渝中医[2021]16号)重庆三峡医药高等专科学校呼吸和老年疾病中医药防治创新研究中心(2024年)重庆三峡医药高等专科学校中医药防治呼吸和老年病团队(TIG202302)
评论